Eikon Therapeutics, Inc. (EIKN)
NASDAQ: EIKN · Real-Time Price · USD
14.91
+0.53 (3.69%)
At close: Mar 9, 2026, 4:00 PM EDT
14.91
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:00 PM EDT
Eikon Therapeutics Market Cap
Eikon Therapeutics has a market cap or net worth of $808.69 million as of March 9, 2026.
Market Cap
808.69M
Enterprise Value
708.38M
1-Year Change
n/a
Ranking
Category
Stock Price
$14.91
Market Cap Chart
Since the IPO on February 5, 2026, Eikon Therapeutics's market cap has decreased from $971.72M to $808.69M, a decrease of -16.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 776.29M | -20.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BridgeBio Oncology Therapeutics | 833.94M |
| Xencor | 830.19M |
| KalVista Pharmaceuticals | 820.37M |
| Omeros | 818.19M |
| MapLight Therapeutics | 807.80M |
| MannKind | 804.14M |
| CytomX Therapeutics | 792.96M |
| Kura Oncology | 791.43M |